Inventor · disambiguated record
John W. Babich
Also filed as: BABICH JOHN · BABICH JOHN W
61 granted patents·29 pending applications·1,074 citations·filing 1986–2025
99Inventor score
Top patents by PatentIndex Score
90 records- 0197US9309193B2Heterodimers of glutamic acidBABICH JOHN W·Filed 2011·Granted Apr 12, 2016·41 cites·19 claims
- 0297US8487129B2Heterodimers of glutamic acidBABICH JOHN W·Filed 2011·Granted Jul 16, 2013·54 cites·56 claims
- 0397US8211402B2CA-IX specific radiopharmaceuticals for the treatment and imaging of cancerBABICH JOHN W·Filed 2009·Granted Jul 3, 2012·46 cites·33 claims
- 0496US9687572B2PSMA-targeted dendrimersBABICH JOHN W·Filed 2011·Granted Jun 27, 2017·30 cites·25 claims
- 0596US8962799B2Technetium—and rhenium-bis(heteroaryl) complexes and methods of use thereofMOLECULAR INSIGHT PHARM INC·Filed 2014·Granted Feb 24, 2015·75 cites·26 claims
- 0696US8926944B2Radiolabeled prostate specific membrane antigen inhibitorsBABICH JOHN W·Filed 2012·Granted Jan 6, 2015·60 cites·7 claims
- 0796US8840865B2Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereofMOLECULAR INSIGHT PHARM INC·Filed 2013·Granted Sep 23, 2014·32 cites·26 claims
- 0896US8211401B2Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting PSMABABICH JOHN W·Filed 2009·Granted Jul 3, 2012·93 cites·20 claims
- 0995US8562945B2Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereofBABICH JOHN W·Filed 2009·Granted Oct 22, 2013·31 cites·23 claims
- 1095US8465725B2Process for production of heterodimers of glutamic acidBABICH JOHN W·Filed 2010·Granted Jun 18, 2013·42 cites·28 claims
- 1195US6395299B1Matrices for drug delivery and methods for making and using the sameBIOSTREAM INC·Filed 2000·Granted May 28, 2002·194 cites·140 claims
- 1294US10806806B2Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapiesUNIV CORNELL·Filed 2018·Granted Oct 20, 2020·8 cites·15 claims
- 1394US6491893B1Compounds for targeting and imaging infection and inflammationBIOSTREAM INC·Filed 2000·Granted Dec 10, 2002·64 cites·27 claims
- 1493US11279698B2Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancerUNIV CORNELL·Filed 2019·Granted Mar 22, 2022·7 cites·6 claims
- 1593US8877970B2Inhibitors of carbonic anhydrase IXZIMMERMAN CRAIG·Filed 2009·Granted Nov 4, 2014·34 cites·9 claims
- 1692US10647666B2Heterodimers of glutamic acidMOLECULAR INSIGHT PHARM INC·Filed 2018·Granted May 12, 2020·2 cites·30 claims
- 1790US9878980B2Heterodimers of glutamic acidMOLECULAR INSIGHT PHARM INC·Filed 2016·Granted Jan 30, 2018·5 cites·3 claims
- 1890US9433594B2Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereofMOLECULAR INSIGHT PHARM INC·Filed 2015·Granted Sep 6, 2016·5 cites·5 claims
- 1989US10179117B2Double targeted constructs to affect tumor killUNIV CORNELL·Filed 2017·Granted Jan 15, 2019·6 cites·20 claims
- 2089US10131627B2Heterodimers of glutamic acidMOLECULAR INSIGHT PHARM INC·Filed 2017·Granted Nov 20, 2018·4 cites·1 claims
- 2189US9956305B2Organ protection in PSMA-targeted radionuclide therapy of prostate cancerMOLECULAR INSIGHT PHARM INC·Filed 2015·Granted May 1, 2018·8 cites·10 claims
- 2289US9447121B2Triazine based radiopharmaceuticals and radioimaging agentsMOLECULAR INSIGHT PHARM INC·Filed 2014·Granted Sep 20, 2016·10 cites·23 claims
- 2388US9120837B2Metal complexes of poly(carboxyl)amine-containing ligands having an affinity for carbonic anhydrase IXMOLECULAR INSIGHT PHARM INC·Filed 2013·Granted Sep 1, 2015·5 cites·31 claims
- 2487US11285227B2Trifunctional constructs with tunablepharmacokinetics useful in imaging and anti-tumor therapiesUNIV CORNELL·Filed 2018·Granted Mar 29, 2022·6 cites·19 claims
- 2587US9388144B2Radiolabeled prostate specific membrane antigen inhibitorsMOLECULAR INSIGHT PHARM INC·Filed 2014·Granted Jul 12, 2016·9 cites·29 claims
- 2687US7556794B2Pendant fatty acid imaging agentsMOLECULAR INSIGHT PHARM INC·Filed 2006·Granted Jul 7, 2009·3 cites·8 claims
- 2786US10086096B2Triazine based radiopharmaceuticals and radioimaging agentsMOLECULAR INSIGHT PHARM INC·Filed 2017·Granted Oct 2, 2018·4 cites·22 claims
- 2886US7052913B2Matrices for drug delivery and methods for making and using the sameMOLECULAR INSIGHT PHARM INC·Filed 2004·Granted May 30, 2006·18 cites·20 claims
- 2985US6437103B1Fatty acid analogs for diagnosis of coronary artery diseaseBIOSTREAM INC·Filed 2000·Granted Aug 20, 2002·22 cites·24 claims
- 3085US2025163040A1Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancerUNIV CORNELL·Filed 2024·Application pending·0 cites
- 3184US10640461B2Heterodimers of glutamic acidMOLECULAR INSIGHT PHARM INC·Filed 2016·Granted May 5, 2020·2 cites·47 claims
- 3284US7438891B2Imaging agents for early detection and monitoring of cardiovascular plaqueELMALEH DAVID R·Filed 2005·Granted Oct 21, 2008·2 cites·10 claims
- 3383US12268759B2Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapiesUNIV CORNELL·Filed 2022·Granted Apr 8, 2025·0 cites·1 claims
- 3483US10201624B2Triazine based radiopharmaceuticals and radioimaging agentsMOLECULAR INSIGHT PHARM INC·Filed 2016·Granted Feb 12, 2019·3 cites·19 claims
- 3583US7381399B2Technetium-dipyridine complexes, and methods of use thereofMOLECULAR INSIGHT PHARM INC·Filed 2003·Granted Jun 3, 2008·12 cites·24 claims
- 3681US6515131B2Imagining agents for diagnosis of Parkinson's diseaseBIOSTREAM THERAPEUTICS INC·Filed 2001·Granted Feb 4, 2003·14 cites·56 claims
- 3781US2024050599A1Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapiesUNIV CORNELL·Filed 2023·Application pending·0 cites
- 3880US12258339B2Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancerUNIV CORNELL·Filed 2022·Granted Mar 25, 2025·0 cites·1 claims
- 3980US2021246103A1Heterodimers of glutamic acidMOLECULAR INSIGHT PHARM INC·Filed 2021·Application pending·0 cites
- 4078US12103922B2Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancerUNIV CORNELL·Filed 2022·Granted Oct 1, 2024·0 cites·15 claims
- 4178US10898598B2Triazine based radiopharmaceuticals and radioimaging agentsMOLECULAR INSIGHT PHARM INC·Filed 2018·Granted Jan 26, 2021·1 cites·24 claims
- 4277US2025214985A1Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancerUNIV CORNELL·Filed 2025·Application pending·0 cites
- 4376US2021070696A1Heterodimers of glutamic acidMOLECULAR INSIGHT PHARM INC·Filed 2020·Application pending·0 cites
- 4474US12377175B2Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapiesUNIV CORNELL·Filed 2020·Granted Aug 5, 2025·0 cites·1 claims
- 4574US12186288B2Double targeted constructs to affect tumor killUNIV CORNELL·Filed 2020·Granted Jan 7, 2025·0 cites·2 claims
- 4673US11712485B2Triazine based radiopharmaceuticals and radioimaging agentsMOLECULAR INSIGHT PHARM INC·Filed 2020·Granted Aug 1, 2023·0 cites·20 claims
- 4773US2021070695A1Heterodimers of glutamic acidMOLECULAR INSIGHT PHARM INC·Filed 2020·Application pending·0 cites
- 4871US10716772B2Double targeted constructs to affect tumor killUNIV CORNELL·Filed 2019·Granted Jul 21, 2020·0 cites·19 claims
- 4971US7875258B2Technetium-dipyridine complexes, and methods of use thereofMOLECULAR INSIGHT PHARM INC·Filed 2008·Granted Jan 25, 2011·1 cites·22 claims
- 5071US5716594ABiotin compounds for targetting tumors and sites of infectionJMDE TRUST·Filed 1996·Granted Feb 10, 1998·40 cites·24 claims
Showing the top 50 of 90 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when John W. Babich files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →